Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × TH 302 × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Sarcoma 1 NET 1 Endocrine 1

Conditions

Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1

Interventions

Everolimus 2 trifluridine tipiracil drug combination 1 pegfilgrastim 1 gallium Ga 68 dotatate 1 fosbretabulin 1 dactolisib 1 Temozolomide 1 TH 302 1 Sunitinib 1 Nivolumab 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02402062 2020-07-27

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed

17 enrolled 55 charts

EndocrineGastrointestinalNET

Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡